(Q43740101)

English

Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

George Mazariegos

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

John Julian Fung

6

object named as

Fung JJ

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

7

object named as

Green M

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

Cacciarelli TV

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Reyes J

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Jaffe R

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Jain A

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Pediatric Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

359-364

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.00021.X

21 January 2018

Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.00021.X

21 January 2018

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.00021.X

21 January 2018

Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: A growing concern

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.00021.X

21 January 2018

Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.00021.X

21 January 2018

Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.00021.X

21 January 2018

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.00021.X

21 January 2018

Antibody-Dependent Lymphocyte Cytotoxicity Against Cells Expressing Epstein—Barr Virus Antigens

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.00021.X

21 January 2018

NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.00021.X

21 January 2018

The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.00021.X

21 January 2018

Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.00021.X

21 January 2018

Epstein-Barr Virus Lymphoproliferative Disease Associated with Acquired Immunodeficiency

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.00021.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1399-3046.2001.00021.X

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

release_zzippvn5q5cktjxocsf7kbe47m

1 reference

https://api.fatcat.wiki/v0/release/zzippvn5q5cktjxocsf7kbe47m

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43740101&oldid=2102955940"